Reported Breast, Colorectal Cancer Screening Higher in 2023 Than 2019

Medically reviewed by Carmen Pope, BPharm. Last updated on March 17, 2025.

By Elana Gotkine HealthDay Reporter

MONDAY, March 17, 2025 -- In 2023, reported breast and colorectal cancer screening rebounded from pandemic-related declines, and rates were higher than in 2019, according to a research letter published online March 5 in the Journal of the American Medical Association.

Jessica Star, M.P.H., from the American Cancer Society in Atlanta, and colleagues obtained data from the National Health Interview Survey to estimate postpandemic cancer screening rates in 2023 relative to previously documented declines through 2021.

In 2023, 6,829, 8,888, and 13,144 individuals were eligible for breast, cervical, and colorectal cancer screening, respectively. The researchers found that the reported past-year breast cancer screening and colorectal screening increased by 7 and 12 percent, respectively, between 2019 and 2023. Rebounds between 2021 and 2023 in breast cancer screening and colonoscopy screening underlay these increases (adjusted prevalence ratios, 1.14 and 1.13, respectively), as did a sustained increase in stool testing (6.6 percent in 2019 and 10.1 percent in 2021 and 2023). In 2023, reported cervical cancer screening remained below 2019 estimates (adjusted prevalence ratio, 0.86), and was unchanged from 2021.

"To prevent further shifts toward later-stage diagnoses, efforts must address declines in cervical cancer screening and disparities by socioeconomic status in all three screening types," the authors write. "Health systems and health care professionals could play a major role by improving screening communications and providing patient navigators to help address structural and cost barriers."

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords